Showing 1 - 13 results of 13 for search 'Powe, N', query time: 0.04s
Refine Results
-
1
The clinical-economic trial: promise, problems, and challenges. by Powe, N, Griffiths, R
Published 1995Journal article -
2
Cost implications to Medicare of recombinant erythropoietin therapy for the anemia of end-stage renal disease. by Powe, N, Griffiths, R, Bass, E
Published 1993Journal article -
3
Simulated lifetime costs of three types of employer-based, periodic, breast cancer screening programs for working-age women. by Griffiths, R, Griffiths, C, Powe, N
Published 1994Journal article -
4
Factors influencing third party payer costs for allogeneic BMT. by Griffiths, R, Bass, E, Powe, N, Anderson, G, Goodman, S, Wingard, JR
Published 1993Journal article -
5
Efficacy of immune globulin in preventing complications of bone marrow transplantation: a meta-analysis. by Bass, E, Powe, N, Goodman, SN, Graziano, S, Griffiths, R, Kickler, T, Wingard, JR
Published 1993Journal article -
6
The production of dialysis by for-profit versus not-for-profit freestanding renal dialysis facilities. by Griffiths, R, Powe, N, Gaskin, D, Anderson, G, de Lissovoy, G, Whelton, P
Published 1994Journal article -
7
Economic impact of immunization against rotavirus gastroenteritis. Evidence from a clinical trial. by Griffiths, R, Anderson, G, Powe, N, Oliveras, E, Herbert, R, Grant, C, Davidson, B
Published 1995Journal article -
8
A review of the first year of Medicare coverage of erythropoietin. by Griffiths, R, Powe, N, Greer, J, de Lissovoy, G, Anderson, G, Whelton, P, Watson, A, Eggers, P
Published 1994Journal article -
9
Medicare payment policy and recombinant erythropoietin prescribing for dialysis patients. by Powe, N, Griffiths, R, Anderson, G, de Lissovoy, G, Watson, A, Greer, J, Herbert, R, Whelton, P
Published 1993Journal article -
10
-
11
Early dosing practices and effectiveness of recombinant human erythropoietin. by Powe, N, Griffiths, R, Greer, J, Watson, A, Anderson, G, de Lissovoy, G, Herbert, R, Eggers, P, Milam, R, Whelton, P
Published 1993Journal article -
12
Access to recombinant erythropoietin by Medicare-entitled dialysis patients in the first year after FDA approval. by Powe, N, Griffiths, R, de Lissovoy, G, Anderson, G, Watson, A, Greer, J, Herbert, R, Eggers, P, Milam, R, Whelton, P
Published 1992Journal article -
13
The relationship of provider organizational status and erythropoietin dosing in end stage renal disease patients. by de Lissovoy, G, Powe, N, Griffiths, R, Watson, A, Anderson, G, Greer, J, Herbert, R, Eggers, P, Milam, R, Whelton, P
Published 1994Journal article